Lead, Innovate, Transform
AEON Biopharma is leading the way as the first and only company focused solely on toxins for therapeutic applications. We are innovating toxin use to improve the lives of patients who are suffering from debilitating medical disorders. AEON is excited to introduce ABP450, the first 900 kDa toxin innovation in the US for over 30 years, and is proud to partner with physicians to advance treatment options.
We are dedicated to enhancing patient lives by leading in new ways to use toxins while improving existing toxin therapy.
Our core values guide our company and
every decision we make.
We recognize the great promise and value that comes from fresh and creative thinking. We aim to transform the therapeutic use of toxins with the introduction of ABP450.
At AEON, we believe that great achievements are realized when passionate people work together towards a compelling vision. In partnership with physicians, we are dedicated to offering relief to more patients.
We understand how difficult it is to suffer from the pain and decreased functionality arising from a medical disorder. At AEON, patients are at the heart of everything we do.
We understand that to innovate we must look forward constantly, adapt effectively and implement quickly.
We believe in building an inspiring vision, setting the direction, and blazing new trails.
Interested in AEON BioPharma?
Learn more about us and our breakthrough toxin therapy treatment.